| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Procedural complication | FAERS: 3 | US FAERS | |
| 2 | Hypotension | FAERS: 2 | US FAERS | |
| 3 | Anxiety | FAERS: 1 | US FAERS | |
| 4 | Bronchospasm | FAERS: 1 | US FAERS | |
| 5 | Cardiac enzymes increased | FAERS: 1 | US FAERS | |
| 6 | Cerebral disorder | FAERS: 1 | US FAERS | |
| 7 | Hypoxia | FAERS: 1 | US FAERS | |
| 8 | Infusion site bruising | FAERS: 1 | US FAERS | |
| 9 | Infusion site swelling | FAERS: 1 | US FAERS | |
| 10 | Injection site extravasation | FAERS: 1 | US FAERS | |
| 11 | Pneumothorax | FAERS: 1 | US FAERS | |
| 12 | Sinus bradycardia | FAERS: 1 | US FAERS | |
| 13 | Tachycardia | FAERS: 1 | US FAERS | |
| 14 | Urticaria | FAERS: 1 | US FAERS | |
| 15 | Prenatal Exposure Delayed Effects | 23429044 | CTD | |
| 16 | Skin Neoplasms | 9714339 | CTD |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.